Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Giulia Maria Stella, Alessandra Gentile, Alice Baderacchi, Federica Meloni, Melissa Milan, Silvia Benvenuti

Research output: Contribution to journalArticle

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) identifies a specific lung disorder characterized by chronic, progressive fibrosing interstitial pneumonia of unknown etiology, which lacks effective treatment. According to the current pathogenic perspective, the aberrant proliferative events in IPF resemble those occurring during malignant transformation. Main body: Receptor tyrosine kinases (RTK) are known to be key players in cancer onset and progression. It has been demonstrated that RTK expression is sometimes also altered and even druggable in IPF. One example of an RTK-the MET proto-oncogene-is a key regulator of invasive growth. This physiological genetic program supports embryonic development and post-natal organ regeneration, as well as cooperating in the evolution of cancer metastasis when aberrantly activated. Growing evidence sustains that MET activation may collaborate in maintaining tissue plasticity and the regenerative potential that characterizes IPF. Conclusion: The present work aims to elucidate-by applying the logic of simplicity-the bio-molecular mechanisms involved in MET activation in IPF. This clarification is crucial to accurately design MET blockade strategies within a fully personalized approach to IPF.

Original languageEnglish
Article number256
JournalJournal of Translational Medicine
Volume14
Issue number1
DOIs
Publication statusPublished - Sep 2 2016

Fingerprint

Idiopathic Pulmonary Fibrosis
Receptor Protein-Tyrosine Kinases
Lung Neoplasms
Chemical activation
Proto-Oncogene Proteins c-met
Growth
Plasticity
Tissue
Interstitial Lung Diseases
Embryonic Development
Regeneration
Neoplasms
Neoplasm Metastasis
Lung

Keywords

  • Cancer
  • Epithelial-to-mesenchymal transition
  • Idiopathic pulmonary fibrosis
  • Invasive growth
  • Precision medicine

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer. / Stella, Giulia Maria; Gentile, Alessandra; Baderacchi, Alice; Meloni, Federica; Milan, Melissa; Benvenuti, Silvia.

In: Journal of Translational Medicine, Vol. 14, No. 1, 256, 02.09.2016.

Research output: Contribution to journalArticle

@article{9a0964cb6fde44a99e3773b5f26ed176,
title = "Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer",
abstract = "Background: Idiopathic pulmonary fibrosis (IPF) identifies a specific lung disorder characterized by chronic, progressive fibrosing interstitial pneumonia of unknown etiology, which lacks effective treatment. According to the current pathogenic perspective, the aberrant proliferative events in IPF resemble those occurring during malignant transformation. Main body: Receptor tyrosine kinases (RTK) are known to be key players in cancer onset and progression. It has been demonstrated that RTK expression is sometimes also altered and even druggable in IPF. One example of an RTK-the MET proto-oncogene-is a key regulator of invasive growth. This physiological genetic program supports embryonic development and post-natal organ regeneration, as well as cooperating in the evolution of cancer metastasis when aberrantly activated. Growing evidence sustains that MET activation may collaborate in maintaining tissue plasticity and the regenerative potential that characterizes IPF. Conclusion: The present work aims to elucidate-by applying the logic of simplicity-the bio-molecular mechanisms involved in MET activation in IPF. This clarification is crucial to accurately design MET blockade strategies within a fully personalized approach to IPF.",
keywords = "Cancer, Epithelial-to-mesenchymal transition, Idiopathic pulmonary fibrosis, Invasive growth, Precision medicine",
author = "Stella, {Giulia Maria} and Alessandra Gentile and Alice Baderacchi and Federica Meloni and Melissa Milan and Silvia Benvenuti",
year = "2016",
month = "9",
day = "2",
doi = "10.1186/s12967-016-1008-4",
language = "English",
volume = "14",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

AU - Stella, Giulia Maria

AU - Gentile, Alessandra

AU - Baderacchi, Alice

AU - Meloni, Federica

AU - Milan, Melissa

AU - Benvenuti, Silvia

PY - 2016/9/2

Y1 - 2016/9/2

N2 - Background: Idiopathic pulmonary fibrosis (IPF) identifies a specific lung disorder characterized by chronic, progressive fibrosing interstitial pneumonia of unknown etiology, which lacks effective treatment. According to the current pathogenic perspective, the aberrant proliferative events in IPF resemble those occurring during malignant transformation. Main body: Receptor tyrosine kinases (RTK) are known to be key players in cancer onset and progression. It has been demonstrated that RTK expression is sometimes also altered and even druggable in IPF. One example of an RTK-the MET proto-oncogene-is a key regulator of invasive growth. This physiological genetic program supports embryonic development and post-natal organ regeneration, as well as cooperating in the evolution of cancer metastasis when aberrantly activated. Growing evidence sustains that MET activation may collaborate in maintaining tissue plasticity and the regenerative potential that characterizes IPF. Conclusion: The present work aims to elucidate-by applying the logic of simplicity-the bio-molecular mechanisms involved in MET activation in IPF. This clarification is crucial to accurately design MET blockade strategies within a fully personalized approach to IPF.

AB - Background: Idiopathic pulmonary fibrosis (IPF) identifies a specific lung disorder characterized by chronic, progressive fibrosing interstitial pneumonia of unknown etiology, which lacks effective treatment. According to the current pathogenic perspective, the aberrant proliferative events in IPF resemble those occurring during malignant transformation. Main body: Receptor tyrosine kinases (RTK) are known to be key players in cancer onset and progression. It has been demonstrated that RTK expression is sometimes also altered and even druggable in IPF. One example of an RTK-the MET proto-oncogene-is a key regulator of invasive growth. This physiological genetic program supports embryonic development and post-natal organ regeneration, as well as cooperating in the evolution of cancer metastasis when aberrantly activated. Growing evidence sustains that MET activation may collaborate in maintaining tissue plasticity and the regenerative potential that characterizes IPF. Conclusion: The present work aims to elucidate-by applying the logic of simplicity-the bio-molecular mechanisms involved in MET activation in IPF. This clarification is crucial to accurately design MET blockade strategies within a fully personalized approach to IPF.

KW - Cancer

KW - Epithelial-to-mesenchymal transition

KW - Idiopathic pulmonary fibrosis

KW - Invasive growth

KW - Precision medicine

UR - http://www.scopus.com/inward/record.url?scp=84984940595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984940595&partnerID=8YFLogxK

U2 - 10.1186/s12967-016-1008-4

DO - 10.1186/s12967-016-1008-4

M3 - Article

VL - 14

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 256

ER -